
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 49
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1225-1233
Open Access | Times Cited: 22
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1225-1233
Open Access | Times Cited: 22
Artemisinin-resistant malaria in Africa demands urgent action
Mehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.
Science (2024) Vol. 385, Iss. 6706, pp. 252-254
Closed Access | Times Cited: 15
Mehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.
Science (2024) Vol. 385, Iss. 6706, pp. 252-254
Closed Access | Times Cited: 15
tRNA modification reprogramming contributes to artemisinin resistance in Plasmodium falciparum
Jennifer L. Small-Saunders, Ameya Sinha, Talia S. Bloxham, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1483-1498
Open Access | Times Cited: 11
Jennifer L. Small-Saunders, Ameya Sinha, Talia S. Bloxham, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1483-1498
Open Access | Times Cited: 11
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
Deus S. Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1807-1808
Closed Access | Times Cited: 11
Deus S. Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1807-1808
Closed Access | Times Cited: 11
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
Artemisinin-resistant malaria
Nicholas J. White, Kesinee Chotivanich
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 9
Nicholas J. White, Kesinee Chotivanich
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 9
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024
Martin Okitwi, Stephen Orena, Patrick K. Tumwebaze, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Martin Okitwi, Stephen Orena, Patrick K. Tumwebaze, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
High Prevalence of Molecular Markers Associated with Artemisinin, Sulphadoxine and Pyrimethamine Resistance in Northern Namibia
Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda
Cecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Cecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug
Anders Björkman, José Pedro Gil, Michael Alifrangis
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e540-e541
Closed Access | Times Cited: 5
Anders Björkman, José Pedro Gil, Michael Alifrangis
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e540-e541
Closed Access | Times Cited: 5
Current status of drug therapy for alveolar echinococcosis
Jing Qiu, A Jide, Lin-Xun Liu, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 11, pp. 1243-1254
Closed Access | Times Cited: 4
Jing Qiu, A Jide, Lin-Xun Liu, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 11, pp. 1243-1254
Closed Access | Times Cited: 4
Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine
Joel Tärning, Nicholas J. White, Arjen M. Dondorp
Clinical Pharmacology & Therapeutics (2025)
Open Access
Joel Tärning, Nicholas J. White, Arjen M. Dondorp
Clinical Pharmacology & Therapeutics (2025)
Open Access
Prevalence of Plasmodium falciparum drug resistance markers pfcrt K76T and pfaat1 S258L in southern Rwanda, 2010 to 2023
Emma Schallenberg, Welmoed van Loon, Djibril Mbarushimana, et al.
The Journal of Infectious Diseases (2025)
Closed Access
Emma Schallenberg, Welmoed van Loon, Djibril Mbarushimana, et al.
The Journal of Infectious Diseases (2025)
Closed Access
Pregnant women as a sentinel population for genomic surveillance of malaria in the Democratic Republic of the Congo: a population-based study
Marie Onyamboko, Varanya Wasakul, Sarah Benie Bakomba, et al.
The Lancet Global Health (2025) Vol. 13, Iss. 3, pp. e479-e487
Closed Access
Marie Onyamboko, Varanya Wasakul, Sarah Benie Bakomba, et al.
The Lancet Global Health (2025) Vol. 13, Iss. 3, pp. e479-e487
Closed Access
Synergistic activity of the ferroptosis inducer RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum
Vella Nikolova, Karen Linnemannstöns, Anastasiia Zahoruiko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Vella Nikolova, Karen Linnemannstöns, Anastasiia Zahoruiko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Gametocyte production and transmission fitness of African and Asian Plasmodium falciparum isolates with differential susceptibility to artemisinins
Nicholas I. Proellochs, Chiara Andolina, Jordache Ramjith, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Nicholas I. Proellochs, Chiara Andolina, Jordache Ramjith, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Formononetin exerts synergistic action with artesunate against multi-drug-resistant P. falciparum arresting ring-to-schizont transition by inducing reactive oxygen species
Saurabh Kumar, Deepak Singh Kapkoti, Pooja Rani Mina, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 6
Closed Access
Saurabh Kumar, Deepak Singh Kapkoti, Pooja Rani Mina, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 6
Closed Access
China’s Malaria R&D Innovations: A Scoping Review from 2013–2023
Shuxun Wang, Wei Ding, Shenning Lu, et al.
Deleted Journal (2025) Vol. 7, Iss. 18, pp. 635-643
Closed Access
Shuxun Wang, Wei Ding, Shenning Lu, et al.
Deleted Journal (2025) Vol. 7, Iss. 18, pp. 635-643
Closed Access
Therapeutic efficacy and safety of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria treatment in Metehara, Central-east Ethiopia
Mahelet Tesfaye, Ashenafi Assefa, Henok Hailgiorgis, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Mahelet Tesfaye, Ashenafi Assefa, Henok Hailgiorgis, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance
Matthew T. Klope, Poulami Talukder, Brian R. Blank, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Matthew T. Klope, Poulami Talukder, Brian R. Blank, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Vesicular mechanisms of drug resistance in apicomplexan parasites
Kasturi Haldar, Souvik Bhattacharjee
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Kasturi Haldar, Souvik Bhattacharjee
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Development of Next-Generation Antimalarial Acridones with Radical Cure Potential
Rozalia A. Dodean, Yuexin Li, Xiaowei Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Rozalia A. Dodean, Yuexin Li, Xiaowei Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Transmissibility of a new Plasmodium falciparum 3D7 bank for use in malaria volunteer infection studies evaluating transmission blocking interventions
Sean Lynch, Azrin N. Abd‐Rahman, Jenny M Peters, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sean Lynch, Azrin N. Abd‐Rahman, Jenny M Peters, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Focusing on ferroptosis in alveolar bone loss during periodontitis: From mechanisms to therapies
Y J Tang, Jianhang Leng, Yankun Luo, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114683-114683
Closed Access
Y J Tang, Jianhang Leng, Yankun Luo, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114683-114683
Closed Access